✦ LIBER ✦

1155 PEG-IFN FOR CHRONIC HEPATITIS C IN CLINICAL PRACTICE: THE PROSPECTIVE PHASE OF THE AIFA STUDY

✍ Scribed by Rosina, F.; Tosti, M.E.; Borghesio, E.; Mele, A.; Minoli, G.; Gasbarrini, A.; Pallone, F.; Carosi, G.; Rizzetto, M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

OC-35 PEG-IFN for chronic hepatitis C in

✍ F. Rosina; M.E. Tosti; E. Borghesio; A. Mele; G. Minoli; A. Gasbarrini; F. Pallo 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 60 KB

P.03.8 PEG-IFN FOR CHRONIC HEPATITIS C I

✍ F. Rosina; T. Maria Elena; E. Borghesio; A. Mele; G. Minoli; A. Gasbarrini; F. P 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 55 KB

T-38 PEG-IFN for hepatitis C in clinical

✍ F. Rosina; M.E. Tosti; E. Borghesio; A. Mele; S. Monastra; R. Bruno; N. Caporaso 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 56 KB

OC.09.7: PEG-IFN FOR HEPATITIS C IN CLIN

✍ F. Rosina; M.E. Tosti; E. Borghesio; A. Mele; S. Monastra; R. Bruno; G. Carosi; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 100 KB

P1205 ELIGIBILITY 2: A PROSPECTIVE, OBSE

✍ Vukotic, R.; Gamal, N.; Andreone, P. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Boceprevir and telaprevir for the treatm

✍ Christophe Hézode 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB